Form 8-K - Current report:
SEC Accession No. 0001628280-25-024659
Filing Date
2025-05-12
Accepted
2025-05-12 16:05:57
Documents
25
Period of Report
2025-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20250512.htm   iXBRL 8-K 31062
2 EX-99.1 q12025-ex991earningsrelease.htm EX-99.1 206642
3 EX-99.2 q12025supplementalearnin.htm EX-99.2 13973
7 aqstlogo.jpg GRAPHIC 14528
8 q12025supplementalearnin001.jpg GRAPHIC 100033
9 q12025supplementalearnin002.jpg GRAPHIC 288790
10 q12025supplementalearnin003.jpg GRAPHIC 123825
11 q12025supplementalearnin004.jpg GRAPHIC 109681
12 q12025supplementalearnin005.jpg GRAPHIC 75350
13 q12025supplementalearnin006.jpg GRAPHIC 71252
14 q12025supplementalearnin007.jpg GRAPHIC 92610
15 q12025supplementalearnin008.jpg GRAPHIC 72134
16 q12025supplementalearnin009.jpg GRAPHIC 30826
  Complete submission text file 0001628280-25-024659.txt   1751381

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20250512.xsd EX-101.SCH 1776
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20250512_lab.xml EX-101.LAB 21629
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20250512_pre.xml EX-101.PRE 12504
27 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20250512_htm.xml XML 2719
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 25934755
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)